Researchers find narcolepsy symptoms the most severe in patients taking dopamine agonists, so clinicians should be cautious in using them.
Sodium oxybate, alone or in combination with modafinil, improved excessive sleepiness in patients with narcolepsy both with and without cataplexy.
Post-hoc analysis of Phase IIb trial finds both clinician and patient-reported improvements in disease status with JZP-110.
The first trial to evaluate sodium oxybate for the treatment of children and adolescents with narcolepsy and cataplexy has started patient enrollment.
Psychiatry Advisor Articles
- Naltrexone-Assisted Detox vs Buprenorphine Taper for Opioid Dependence
- Suicide Prevention and Intervention: Cross-Cultural Perspectives
- Pediatric Patients Should Undergo Electrocardiogram Assessment Before Antipsychotic Treatment
- Which Antidepressants May Cause Birth Defects?
- Best Practices for Treatment of Bipolar Disorder